SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549 

___________ 

FORM 8-K 

CURRENT REPORT 

PURSUANT TO SECTION 13 OR 15(d) OF THE 

SECURITIES EXCHANGE ACT OF 1934 

 Date of report (Date of earliest event reported)  February 11, 2016  

 VARIAN MEDICAL SYSTEMS, INC. 

 (Exact Name of Registrant as Specified in its Charter)  

  [DATA_TABLE_REMOVED] 

 3100 Hansen Way, Palo Alto, CA 94304-1030 

 (Address of Principal Executive Offices) (Zip Code)  

 Registrant's telephone number, including area code (650) 493-4000  

 Not Applicable 

 (Former Name or Former Address, if Changed Since Last Report)  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Item 5.07 Submission of Matters to a Vote of Security Holders 

The Annual Meeting of Stockholders of Varian Medical Systems, Inc. (the “Company”) was held on February 11, 2016 (the “Stockholders’ Meeting”). The Company’s stockholders voted on the following three proposals at the Stockholders’ Meeting and cast their votes as follows: 

Proposal One: 

The following individuals were elected to serve as directors for one-year terms ending with the 2017 Annual Meeting of Stockholders by the votes set forth in the following table: 

  [DATA_TABLE_REMOVED] 

Directors Susan L. Bostrom, Regina E. Dugan, Timothy E. Guertin, David J. Illingworth, Ruediger Naumann-Etienne, Venkatraman Thyagarajan and Dow R. Wilson continued in office following the Stockholders’ Meeting. 

Proposal Two: 

The stockholders approved, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, by the votes set forth in the following table: 

  [DATA_TABLE_REMOVED] 

Proposal Three: 

The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2016 was ratified, by the votes set forth in the following table: 

  [DATA_TABLE_REMOVED] 

 (1)Pursuant to the rules of the New York Stock Exchange, this proposal constituted a routine matter. Therefore, brokers were permitted to vote without receipt of instructions from beneficial owners. 

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 [DATA_TABLE_REMOVED] 

Dated: February 12, 2016